BNC.AX: Summary for BIONICHE CDI 1:1- Yahoo!7 Finance

Skip to search.

Yahoo! Finance

Sat 25 May 2013 02:31 - Australia Markets closed

1.52%

Streaming

Ticker Tape: On

More On BNC.AX

Quotes

Summary
Order Book
Options
Historical Prices

Charts

News & Info

Headlines
Company Events

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Analyst Opinion
Analyst Estimates

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

Income Statement
Balance Sheet
Cash Flow

BIONICHE CDI 1:1 (BNC.AX)

-ASX

0.35 0.00(0.00%) 17 May 15:52

Add to Portfolio

Prev Close:	0.35
Open:	0.35
Bid:	0.16
Ask:	0.38
1y Target Est:	N/A
Beta:	N/A
Next Earnings Date:	N/A

Day's Range:	0.35 - 0.35
52wk Range:	0.19 - 0.65
Volume:	11,670
Avg Vol (3m):	4,870
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in AUD.

Headlines

Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Resultsat Reuters(Fri 8 Feb)
Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 ResultsCNW Group(Thu 7 Feb)
Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 ResultsCNW Group(Thu 7 Feb)
Bioniche Life Sciences Inc. Terminates its License Agreement with Trophogen Inc.at Reuters(Fri 1 Feb)
Bioniche Life Sciences Inc. met fin à son entente de licence avec Trophogen IncCNW(Thu 31 Jan)
Bioniche Life Sciences Inc. Terminates its License Agreement with Trophogen Inc.CNW Group(Thu 31 Jan)
Bioniche Life Sciences Inc. Terminates its License Agreement with Trophogen Inc.CNW Group(Thu 31 Jan)
Bioniche Life Sciences Inc. Launches Two New Animal Health Products in Canadaat Reuters(Sat 26 Jan)
Bioniche Life Sciences Inc. Launches Two New Animal Health Products in CanadaCNW Group(Fri 25 Jan)
Bioniche Life Sciences Inc. lance deux nouveaux produits de santé animale au CanadaCNW(Fri 25 Jan)

» More Headlines for BNC.AX

Press Releases

Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health BusinessCNW Group(Tue 14 May)
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 ResultsCNW Group(Thu 9 May)
Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder MeetingCNW Group(Sat 4 May)

» More Press Releases for BNC.AX

BIONICHE CDI 1:1 (BNC.AX)

customise chart

Key Statistics

Forward P/E (1 yr):	N/A
P/S (ttm):	N/A
Ex-Dividend Date:	N/A

Analysts

Annual EPS Est () :	N/A
Quarterly EPS Est () :	N/A
Mean Recommendation*:	N/A
PEG Ratio (5 yr expected):	N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

No business summary available forBNC.AX.

Toolbox

Copyright © 2010 Yahoo!7 Pty Limited. All rights reserved.

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo!7 nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo!7 site, you agree not to redistribute the information found therein.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. Real-Time quotes provided by BATS Exchange. US Financials data provided by Edgar Online and all other Financials provided by Capital IQ.